Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Where Retatrutide Sits in Crowded Field Retatrutide would sit at the top of the obesity drug efficacy hierarchy if approved above Lilly's own Zepbound and oral obesity pill Foundayo (orforglipron), which launched in April 2026 at $149 per month at the starting dose
GLP-1 Therapies Our practice offers GLP-1 therapies as part of a physician-supervised weight management program
In clinical trials: People achieved an average weight loss of 15% in just over a year In studies lasting 7 months to just over a year, semaglutide helped most people with type 2 diabetes (66-80%) reach their target HbA1c of less than 7% The medication also helped people with heart disease by reducing their risk of heart attacks, strokes, and heart-related deaths by 20% Side effects Like most medications, semaglutide can cause side effects
Frequently Asked Questions (FAQs) What are weight loss injections used for
GLP-1 significa pptido similar al glucagn tipo 1, una hormona que el intestino libera de manera natural en respuesta a la ingesta de alimentos
Day one is on its way
US$ 21.27
US$ 20.52
US$ 27.65
US$ 28.79
US$ 29.41
US$ 28.36
US$ 28.19
US$ 27.29
